Nissinen, L <br/><br/>
A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapy.  [electronic resource] 

 -  Thrombosis and haemostasis  Feb 2010 
 - 387-97 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH09-06-0358  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspirin--pharmacology<br/>Bleeding Time<br/>Blood Coagulation--drug effects<br/>Collagen--metabolism<br/>Drug Evaluation, Preclinical<br/>Fibrinolytic Agents<br/>Hemostasis--drug effects<br/>Integrin alpha2beta1--antagonists & inhibitors<br/>Mice<br/>Platelet Aggregation Inhibitors--chemistry<br/>Protein Binding--drug effects<br/>Sulfonamides--chemistry<br/>Thrombosis--drug therapy